By Chelsea Whyte
DNA sequencing is getting faster and cheaper, and it has been used to diagnose rare disorders in very sick children. But should it become a standard practice for healthy newborns? That’s the question asked by the BabySeq project, which has just released results from the first phase of its study.
The sequencing trial included 32 sick infants in the intensive care units at three Boston-area hospitals, and 127 healthy children enrolled through the nursery at Brigham and Women’s Hospital in Boston.
Quarterly by Direct Debit
Inclusive of applicable taxes (VAT)